TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | -2 | -7 | -21 | -18 | 2 | -7 | -9 |
| S | %wins | 100 | 100 | 100 | 100 | 0 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/19/18 16:42 | 1/17/18 | ENZ | Enzo Biochem Inc | NY | Health | Health | Medical Laboratories | Rabbani Elazar | NY | DO | CEO,Chn. | S.d | -109 | 7.75 | 0 | -14 | -1 | 1,839 | D | ||||||||||||||
10/27/17 17:05 | 10/25/17 | ENZ | Enzo Biochem Inc | NY | Health | Health | Medical Laboratories | Rabbani Elazar | NY | DO | CEO,Chn. | S.d | -731 | 10.09 | 0 | -72 | -4 | 1,919 | D | ||||||||||||||
4/22/04 20:29 | 4/20/04 | ENZ | Enzo Biochem Inc | NY | Health | Health | Medical Laboratories | Rabbani Elazar | NY | DO | CB BOD,C | S | -54 | 16.32 | 2 | -3 | 0 | 2,110 | D | -18 | 18 | -19 | -22 | -12 | -6 | -6 | -1 | -2 | -7 | -21 | -18 | 2 | -7 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |